Literature DB >> 2730664

Hydrodynamic and circular dichroic analysis of mammary-derived growth inhibitor (MDGI).

J Behlke1, M Mieth, F D Böhmer, R Grosse.   

Abstract

The mammary-derived growth inhibitor exists in solution as a monomeric molecule with a molar mass of 14,500 +/- 400 g/mol. The largest diameter and the height of the polypeptide chain were estimated to be 3.75 +/- 0.25 nm and 2.01 +/- 0.13 nm respectively. This is in good agreement with the structurally related bovine peripheral myelin P2 protein (about 70% amino acid sequence homology). CD measurements have revealed MDGI to be a protein with about 50% beta structure and less than 20% alpha helix similarly as in fatty acid-binding proteins. Removal of endogenous long-chain fatty acid by lipidex or storage in the frozen state lead to a destabilization of the active MDGI conformation which is accompanied by a loss of its activity with regard to growth inhibition of Ehrlich Ascites cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2730664     DOI: 10.1016/0006-291x(89)91606-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Characteristics of fatty acid-binding proteins and their relation to mammary-derived growth inhibitor.

Authors:  F Spener; C Unterberg; T Börchers; R Grosse
Journal:  Mol Cell Biochem       Date:  1990 Oct 15-Nov 8       Impact factor: 3.396

2.  Modulation of the beta-adrenergic-response in cultured rat heart cells. II. Mammary-derived growth inhibitor (MDGI) blocks induction of beta-adrenergic supersensitivity. Dissociation from lipid-binding activity of MDGI.

Authors:  G Wallukat; F D Boehmer; U Engstroem; P Langen; M Hollenberg; J Behlke; H Kuehn; R Grosse
Journal:  Mol Cell Biochem       Date:  1991-03-27       Impact factor: 3.396

Review 3.  Functions of fatty acid binding proteins.

Authors:  R M Kaikaus; N M Bass; R K Ockner
Journal:  Experientia       Date:  1990-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.